Dashboard E. coli
Repurposing candidates for E. coli
Escherichia coli
Approved medicines with AI-predicted activity ≥40% against E. coli, leaving out medicines that are already antimicrobials. Each is shown with what it is already used for. They are surfaced computationally for further investigation, not as treatments.
- AI-predicted activity ≥40%
- 467
- Existing antimicrobials set aside
- 103
- Needing review
- 28
- Repurposing candidates
- 336
Repurposing candidates for E. coli
AI prediction · nothing measuredAll 336 repurposing candidates for E. coli.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- Levocabastine HydrochlorideExisting use: Eye allergy, Nasal congestion49.5% AI-predicted activityagainst E. coli5 registered studies
- SaquinavirExisting use: HIV infection, HIV-1 infection, Viral disease49.4% AI-predicted activityagainst E. coli50+ registered studies
- Ibrexafungerp CitrateExisting use: Vulvovaginal candidiasis49.4% AI-predicted activityagainst E. coliNo documented evidence found
- Mobocertinib SuccinateExisting use: Neoplasm, Non-small cell lung carcinoma49.2% AI-predicted activityagainst E. coliNo documented evidence found
- SparsentanExisting use: IGA glomerulonephritis49.2% AI-predicted activityagainst E. coli11 registered studies
- Epinastine HydrochlorideExisting use: Allergic conjunctivitis, Allergic disease, Eye allergy49.0% AI-predicted activityagainst E. coli10 registered studies
- Omidenepag IsopropylExisting use: Ocular hypertension, Open-angle glaucoma49.0% AI-predicted activityagainst E. coli1 registered study
- LesinuradExisting use: Gout, Hyperuricemia49.0% AI-predicted activityagainst E. coli22 registered studies
- Imatinib MesylateExisting use: Acute lymphoblastic leukemia, B-cell acute lymphoblastic leukemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive and 7 more48.9% AI-predicted activityagainst E. coli50+ registered studies
- Prucalopride SuccinateExisting use: Constipation, Constipation disorder48.9% AI-predicted activityagainst E. coli7 registered studies
- FamciclovirExisting use: Eye infection, Genital herpes, Herpes Labialis and 3 more48.8% AI-predicted activityagainst E. coli25 registered studies
- AbemaciclibExisting use: Breast cancer, Breast carcinoma, Breast neoplasm and 3 more48.7% AI-predicted activityagainst E. coli50+ registered studies
- Nintedanib EsylateExisting use: Idiopathic pulmonary fibrosis, Interstitial pneumonitis, Non-small cell lung carcinoma and 1 more48.5% AI-predicted activityagainst E. coli50+ registered studies
- TicagrelorExisting use: Acute coronary syndrome, Acute myocardial infarction, Coronary artery disease and 6 more48.5% AI-predicted activityagainst E. coli50+ registered studies
- RegadenosonExisting use: Cardiovascular disease, Myocardial Perfusion Imaging48.4% AI-predicted activityagainst E. coli50+ registered studies
- Vinblastine SulfateExisting use: Classic Hodgkin lymphoma, Fungal infectious disease, Hodgkins lymphoma and 3 more48.2% AI-predicted activityagainst E. coli50+ registered studies
- Lazertinib MesylateExisting use: Non-small cell lung carcinoma48.2% AI-predicted activityagainst E. coliNo documented evidence found
- SitagliptinExisting use: Diabetes mellitus, Hyperlipidemia, Myocardial infarction and 2 more48.2% AI-predicted activityagainst E. coli50+ registered studies
- ClozapineExisting use: Psychosis, Schizoaffective disorder, Schizophrenia48.1% AI-predicted activityagainst E. coli50+ registered studies
- FutibatinibExisting use: Cancer, Cholangiocarcinoma, Neoplasm48.0% AI-predicted activityagainst E. coli25 registered studies
- Atazanavir SulfateExisting use: HIV infection, HIV-1 infection, Infection and 1 more48.0% AI-predicted activityagainst E. coli50+ registered studies
- Daclatasvir DihydrochlorideExisting use: Chronic hepatitis C virus infection, Viral disease48.0% AI-predicted activityagainst E. coli2 registered studies
- AripiprazoleExisting use: Aggressive behavior, Agitation, Autism and 8 more48.0% AI-predicted activityagainst E. coli50+ registered studies
- Alclometasone DipropionateExisting use: Eye inflammation, Skin disease47.9% AI-predicted activityagainst E. coli2 registered studies